tradingkey.logo

Sensus Healthcare Inc

SRTS
View Detailed Chart

3.110USD

-0.030-0.96%
Close 09/19, 16:00ETQuotes delayed by 15 min
51.13MMarket Cap
LossP/E TTM

Sensus Healthcare Inc

3.110

-0.030-0.96%
Intraday
1m
30m
1h
D
W
M
D

Today

-0.96%

5 Days

-2.20%

1 Month

-2.81%

6 Months

-34.94%

Year to Date

-55.06%

1 Year

-47.38%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
109 / 207
Overall Ranking
247 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 5 analysts
Buy
Current Rating
8.000
Target Price
+154.78%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Growing
The company is in a growing phase, with the latest annual income totaling USD 41.81M.
Undervalued
The company’s latest PE is -59.85, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 7.09M shares, decreasing 22.77% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 740.02K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.03.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Sensus Healthcare, Inc. is a medical device company. The Company is focused on providing non-invasive treatments for both oncological and non-oncological skin conditions. The Company uses a low-energy X-ray technology known as superficial radiation therapy (SRT). The Company incorporated SRT into its portfolio of treatment devices: the SRT-100, SRT-100+ and SRT-100 Vision. SRT-100, is a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. Its SRT-100+ offer remote diagnostics solutions, including operation tracking.
Ticker SymbolSRTS
CompanySensus Healthcare Inc
CEOMr. Joseph C. Sardano
Websitehttps://sensushealthcare.com/
KeyAI